Rankings
▼
Calendar
PRAX FY 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+249.5% YoY
Gross Profit
-$144M
-1682.0% margin
Operating Income
-$200M
-2340.3% margin
Net Income
-$183M
-2137.5% margin
EPS (Diluted)
$-10.21
Cash Flow
Operating Cash Flow
-$132M
Free Cash Flow
-$132M
Stock-Based Comp.
$41M
Balance Sheet
Total Assets
$483M
Total Liabilities
$38M
Stockholders' Equity
$445M
Cash & Equivalents
$215M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$2M
+249.5%
Gross Profit
-$144M
-$84M
-70.6%
Operating Income
-$200M
-$126M
-58.4%
Net Income
-$183M
-$123M
-48.3%
← Q4 2023
All Quarters
Q1 2024 →